Eurofins Pharma Services Newsletter 09 - October 2014
ARTICLES:
- Eurofins BioPharma Product Testing expands global ID Footprint
- Eurofins Lancaster Laboratories expands cell banking capabilities,meeting stringent grade A/Grade B EU requirements
- Cleaning validation: health based exposure limits in shared facilities
- Step into the Future: Trendsetting role of BSL BIOSERVICE in animal-free medical device testing
- Taking fingerprints of medical devices - Chemical characterisation according to ISO 10993-18
- Eurofins selected to be a partner of Cosmetics Europe Task Force Skin Bioavailability and Metabolism Project
- Pharma Events
> Download the pdf version of the newsletter N°9
Receive the next newsletter via email
